儿童难治性支原体肺炎的联合预测因子

付帅, 秦选光

中国儿童保健杂志 ›› 2021, Vol. 29 ›› Issue (4) : 455-457.

PDF(382 KB)
PDF(382 KB)
中国儿童保健杂志 ›› 2021, Vol. 29 ›› Issue (4) : 455-457. DOI: 10.11852/zgetbjzz2020-1536
经验交流

儿童难治性支原体肺炎的联合预测因子

  • 付帅, 秦选光
作者信息 +

Research on the combined predictors of refractory mycoplasma pneumonia in children

  • FU Shuai, QIN Xuan-guang
Author information +
文章历史 +

摘要

目的 筛选可用于区分儿童支原体肺炎(MPP)及难治性支原体肺炎(RMPP)的危险因素,确定预测RMPP的联合因子,为RMPP患儿定制精准治疗和用药方案提供依据。方法 纳入2016年1月1日—2018年12月31日期间入住首都医科大学附属北京朝阳医院儿科的141例MPP患儿,收集临床资料及实验室检查数据。按照前3天治疗效果分为MPP组和RMPP组。通过单因素分析初步筛选出与RMPP有关的危险因素,再建立多因素Logistic回归模型并经逐步回归筛选出独立危险因素,绘制联合因子的受试者工作特征曲线(ROC)进行预测效能分析。结果 本研究纳入141例,其中MPP85例,RMPP56例。单因素分析结果显示,年龄、胸腔积液、咳嗽持续时间、C反应蛋白(CRP)、红细胞沉降率(ESR)、淋巴细胞计数(LY)、淋巴细胞百分比(LY%)在MPP组与RMPP组间差异有统计学意义(P<0.05)。最终将胸腔积液、发热持续时间、咳嗽持续时间、CRP和LY%作为联合因子建立RMPP预测模型,AUC为0.834(95%CI:0.768~0.900),Youden指数最大为0.522,敏感性为80.4%,特异性为71.8%。结论 本研究为RMPP患儿构建了合并胸腔积液、发热持续时间、咳嗽持续时间、CRP和LY%指标的联合预测模型,对于RMPP的预测诊断和糖皮质激素的使用具有临床指导意义。

Abstract

Objective To study the risk factors that can be used to distinguish children's refractory mycoplasma pneumonia (RMPP) from mycoplasma pneumonia (MPP),thus to determine the combined predictors for predicting RMPP,so as to provide basis for customizing accurate treatment and medication plan for RMPP children. Methods A total of 141 children with MPP admitted to Beijing Chaoyang Hospital Affiliated to Capital Medical University from January 1st,2016 to December 31st,2018 were included,and clinical data and laboratory examination data were collected. The patients were divided into MPP group and RMPP group according to the therapeutic efficacy of the first 3 days. The risk factors related to RMPP were preliminarily screened out by univariate analysis,and a multivariate Logistic regression model was established and independent risk factors were selected through stepwise regression. Finally,the receiver operating characteristic curve (ROC) of combined factors was drawn for prediction efficiency analysis. Results There were 85 cases of MPP and 56 cases of RMPP among 141 children.Age,pleural effusion,cough duration,C-creactive protein (CRP),erythrocyte sedimentation rate (ESR),lymphocyte count (LY)and percentage of lymphocytes (LY%) were significantly different between MPP group and RMPP group (P<0.05). Pleural effusion,fever duration,cough duration,CRP and LY% finally entered the prediction model of RMPP,with AUC of 0.834(95%CI:0.768—0.900),Youden index of 0.522 at the maximum. And the sensitivity and specificity were 80.4% and 71.8%,respectively. Conclusion This study constructs a combined model for predicting RMPP with pleural effusion,fever duration,cough duration,CRP,LY%,which has clinical guiding significance for the predictive diagnosis of RMPP and the use of glucocorticoids.

关键词

支原体肺炎 / 难治性支原体肺炎 / 联合预测因子

Key words

mycoplasma pneumonia / refractory mycoplasma pneumonia / combined predictor

引用本文

导出引用
付帅, 秦选光. 儿童难治性支原体肺炎的联合预测因子[J]. 中国儿童保健杂志. 2021, 29(4): 455-457 https://doi.org/10.11852/zgetbjzz2020-1536
FU Shuai, QIN Xuan-guang. Research on the combined predictors of refractory mycoplasma pneumonia in children[J]. Chinese Journal of Child Health Care. 2021, 29(4): 455-457 https://doi.org/10.11852/zgetbjzz2020-1536
中图分类号: R725.6   

参考文献

[1] 中华人民共和国国家健康委员会,国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J].中华临床感染病杂志,2019,12(1):6-13.
[2] 中华医学会儿科学分会临床检验学组.儿童肺炎支原体呼吸道感染实验室诊断中国专家共识[J].中华检验医学杂志,2019,42(7):507-513.
[3] 陈志敏,尚云晓,赵顺英,等.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[4] 闻玉梅.现代医学微生物学[M].上海:上海医科大学出版社,1999:592-602.
[5] 姜艳群,孔小行.146例儿童感染性胸腔积液病因分析[J].中国感染控制杂志,2013,12(6):409-411.
[6] 郑宝英,曹玲.儿童支原体肺炎合并胸腔积液诊断及处理[J].中国实用儿科杂志,2017,32(3):171-174.
[7] 李雪冰,荀春铮.儿童肺炎支原体感染后咳嗽发作时辰、病程分布特征及其与中医证型的相关性[J].中医药导报,2019,25(24):57-58,63.
[8] 陈艳丽.血清CRP在小儿支原体肺炎诊治中的价值[J].医学信息,2019,32(18):181-182.
[9] 刘金荣,彭芸,杨海明,等.难治性肺炎支原体肺炎的表现特征和判断指标探讨[J].中华儿科杂志,2012,50(12):915-918.
[10] 李晓娟,安俊杰.肺炎支原体感染患儿免疫球蛋白、补体及T淋巴细胞亚群的水平[J].中国临床医生杂志,2019,47(3):361-363.
[11] 秦正积,沈毅,崔晓莉,等.Logistic回归在疾病多指标联合诊断中的应用[J].中国卫生统计,2014,31(1):116-117.
[12] Tagliabue C,Salvatore CM,Techasaensiri C,et al.The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection[J].J Infect Dis,2008,198(8):1180-1188.
[13] Bassetti M,Montero JG,Paiva JA.When antibiotic treatmentfails[J].Intensive Care Med,2018,44(1):73-75.
[14] 洪建国.糖皮质激素在重症支原体肺炎治疗中的应用[J].中国实用儿科杂志,2015,30(3):170-173.
[15] 林志雄,王开梅,陈江,等.不同剂量糖皮质激素辅助治疗小儿难治性肺炎支原体肺炎合并肺外并发症疗效比较[J].中国医院药学杂志,2017,37(7):639-642.

PDF(382 KB)

Accesses

Citation

Detail

段落导航
相关文章

/